ICG, Ares Management and Groupe Bruxelles Lambert (GBL) are among the handful of parties still fighting it out for DACH ophthalmology asset Sanoptis, according to two sources familiar with the situation.
ICG, Ares Management and Groupe Bruxelles Lambert (GBL) are among the handful of parties still fighting it out for DACH ophthalmology asset Sanoptis, according to two sources familiar with the situation.